Refine by
Nucleic Acid Articles & Analysis: This-Year
7 articles found
Their nanoscale size, biocompatibility, and ability to encapsulate therapeutic agents make them suitable carriers for both small molecules and larger biomolecules like proteins and nucleic acids. VLPs can improve the bioavailability and stability of drugs while enabling targeted delivery to specific tissues or cells, thus enhancing therapeutic outcomes. ...
REBASE--a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Research. 2015;43(Database issue):D298-D299. DOI: 10.1093/nar/gku1046 Pingoud A, Wilson GG, Wende W. Type II restriction endonucleases--a historical perspective and more. Nucleic Acids Research. 2014;42(12):7489-7527. DOI: ...
REBASE--a database for DNA restriction and modification: enzymes, genes and genomes. Nucleic Acids Research. 2015;43(Database issue):D298-D299. DOI: 10.1093/nar/gku1046 Pingoud A, Wilson GG, Wende W. Type II restriction endonucleases--a historical perspective and more. Nucleic Acids Research. 2014;42(12):7489-7527. DOI: ...
It employs fluorescent probes that bind to the target nucleic acid sequences, allowing researchers to visualize genetic anomalies, chromosomal rearrangements, and structural variations. ...
Nano-sized vesicles called PEVs originate from natural cells and transport diverse contents from parent cells including nucleic acids as well as proteins and lipids. Activated platelet secretion produces most of the plasma vesicles which represent between 70% and 90% of plasma derivatives. ...
The utilization of bright field microscopy allows for clear visualization of traditional ISH, where localization of nucleic acids within various biological samples can be achieved with remarkable clarity. ...
By analyzing exosomal metabolites—ranging from amino acids to lipids to sugars—researchers can identify biomarkers that reflect the metabolic alterations that characterize different disease states. ...